Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Taiwan University Hospital |
---|---|
Information provided by: | National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT00174174 |
The primary objective is to evaluate the therapeutic effect of excessive daytime sleepiness associated with narcolepsy. Both of the subjective and objective sleepiness of the patients were assessed in the experiment by repeat measures.
Condition | Intervention |
---|---|
Narcolepsy Cataplexy Sleep Disorders Hypersomnolence Excessive Sleepiness |
Drug: Modafinil |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study |
Official Title: | A Placebo Control, Double Blind, Cross Over Study of Modafinil in Patients With Narcolepsy |
Estimated Enrollment: | 30 |
Study Start Date: | September 2003 |
Ages Eligible for Study: | 12 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 920203l |
Study First Received: | September 14, 2005 |
Last Updated: | September 14, 2005 |
ClinicalTrials.gov Identifier: | NCT00174174 |
Health Authority: | Taiwan: Department of Health |
Signs and Symptoms Cataplexy Mental Disorders Narcolepsy Neurologic Manifestations Dyssomnias |
Sleep Disorders Disorders of Excessive Somnolence Modafinil Gelineau's syndrome Sleep Disorders, Intrinsic |
Therapeutic Uses Physiological Effects of Drugs Nervous System Diseases Central Nervous System Stimulants |
Protective Agents Neuroprotective Agents Central Nervous System Agents Pharmacologic Actions |